PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant

NCT03699631 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancy

Interventions

DRUG: Tacrolimus
DRUG: Methotrexate
DRUG: Tocilizumab

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]